It is likely that TBX2 and/or TBX3 account for the function of HDACs in repression of cyclin-dependent kinase inhibitor gene expression in at least some cancer types, and that TBX2 or of its specific interaction with HDACs represent valuable highly specific targets for anti-cancer therapy. Here, TBX3 is linked to cancer.